SecBot SecBot
8-K ·Filed May 7, 2026

SHPH

Shuttle Pharmaceuticals Holdings, Inc.
BEARISH
Impact 8/10
Horizonweeks Processed6mo ago SEC0001493152-26-021767
Killer combo: M&A completed + management change
Actionable Insight ▼ Bearish

Expect extreme dilution pressure on SHPH shares as the market prices in the new crypto mining business and pending stockholder vote. Watch for the registration statement and stockholder approval timeline, if delayed, further downside risk. The prior close of the PIPE at $9.55M suggests new investors see value, but existing common shareholders face severe dilution.

DirectionBearish
Confidencehigh
Horizonweeks

How the stock moved after the report

BEARISH VIEWSTOCK BELOW ENTRY AT T+60
Entry
$6.89
T+0 close · May 7, 2026 · via day close
Latest settled
−47.02%
T+60 · $3.65
Vs SPY
−51.86%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · May 8 $6.89entry
  2. T+1 · 6mo ago −1.45%α −1.68% · $6.79
  3. T+5 · 6mo ago −3.34%α −3.55% · $6.66
  4. T+20 · 5mo ago −29.75%α −29.97% · $4.84
  5. T+60 · 3mo ago −47.02%α −51.86% · $3.65

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Shuttle Pharmaceuticals completed its merger with United Dogecoin Inc., transforming into a crypto mining company. Existing shareholders received Series B-1 preferred stock convertible into common shares only after stockholder approval, and massively dilutive PIPE financing of $9.55M closed alongside the merger. The deal effectively transfers control to United Dogecoin holders and dilutes existing SHPH shareholders severely.

Key Financial Metrics

Deal Type
merger
Offering Size
$9.6M
Dilution
2300%

Key Facts

  • Merger completed on May 6, 2026; United Dogecoin becomes wholly owned subsidiary.
  • Existing United Dogecoin holders received 8,403 shares of Series B-1 Preferred Stock, convertible into 33,889,899 common shares at $1.24 (subject to stockholder approval and 4.99% cap).
  • PIPE financing of $9,550,000 closed through issuance of 1,910 Series B-2 Preferred Shares convertible into 9,271,845 common shares at $1.03, plus common warrants.
  • Pre-funded warrants for up to 122,927,528 common shares issuable to pre-merger United Dogecoin holders upon meeting milestones.
  • Additional Series B-1 shares and warrants issued to financial advisor E.F. Hutton & Co. and to a seller of assets.
  • Director Oleh Nabyt resigned; Ryan Trasolini appointed Co-CEO.
  • Market cap approximately $4M at filing.

Financial Impact

Massive dilution: PIPE alone adds ~9.3M shares; full conversion of all Series B-1 and warrants could add over 150M shares, dwarfing current ~4M market cap.

dilutionmarket capownership structure

Risk Factors

  • Stockholder approval may be delayed or denied, preventing conversion of preferred shares.
  • No financial statements filed yet (due within 74 days); uncertainty about United Dogecoin's financials.
  • Crypto mining profitability is volatile; no revenue from the new business disclosed.
  • Potential delisting if stock price remains low post-merger.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001493152-26-021767
Document: 0001493152-26-021767-index-headers.html0001493152-26-021767
Document: 0001493152-26-021767-index.html0001493152-26-021767
Document: 0001493152-26-021767.txt0001493152-26-021767

US Market Status

Market Closed · Opens Wed (10h 9m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published May 7, 2026